Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Journal of Hepatology
|
August 20, 2022
Reply to: Correspondence on "Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection"
Jonggi Choi
Gut and Liver
|
March 14, 2023
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
February 17, 2025
Editorial: Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab for Hepatocellular Carcinoma-Don't Ignore the Risk Factors! Authors' Reply
Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
March 24, 2024
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B-Author's reply
Hyeyeon Hong, Jonggi Choi
Clinical and Molecular Hepatology
|
March 6, 2024
Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
January 22, 2024
Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments-Authors' reply
Hyeyeon Hong, Jonggi Choi
The American Journal of Gastroenterology
|
August 30, 2023
Response to Liaw
Jiwon Yang, Jonggi Choi
JHEP Reports : Innovation in Hepatology
|
June 11, 2025
Reply to: "Surveillance for hepatocellular carcinoma in patients with primary biliary cholangitis: For all or just for some?"
Jihye Lim, Jonggi Choi
Clinical and Molecular Hepatology
|
February 21, 2024
Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply
Hyeyeon Hong, Jonggi Choi
Clinical and Molecular Hepatology
|
January 9, 2026
Reaffirming the Role of SGLT2 Inhibitors in Slowing Fibrotic Progression in MASLD
Jonggi Choi, Raymond T Chung
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Journal of Hepatology
|
August 20, 2022
Reply to: Correspondence on "Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection"
Jonggi Choi
Gut and Liver
|
March 14, 2023
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
February 17, 2025
Editorial: Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab for Hepatocellular Carcinoma-Don't Ignore the Risk Factors! Authors' Reply
Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
March 24, 2024
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B-Author's reply
Hyeyeon Hong, Jonggi Choi
Clinical and Molecular Hepatology
|
March 6, 2024
Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Alimentary Pharmacology & Therapeutics
|
January 22, 2024
Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments-Authors' reply
Hyeyeon Hong, Jonggi Choi
The American Journal of Gastroenterology
|
August 30, 2023
Response to Liaw
Jiwon Yang, Jonggi Choi
JHEP Reports : Innovation in Hepatology
|
June 11, 2025
Reply to: "Surveillance for hepatocellular carcinoma in patients with primary biliary cholangitis: For all or just for some?"
Jihye Lim, Jonggi Choi
Clinical and Molecular Hepatology
|
February 21, 2024
Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply
Hyeyeon Hong, Jonggi Choi
Clinical and Molecular Hepatology
|
January 9, 2026
Reaffirming the Role of SGLT2 Inhibitors in Slowing Fibrotic Progression in MASLD
Jonggi Choi, Raymond T Chung
Page
of 14